Nanized Devils'Claw

Quantum Devil's Claw Benefits

• Healthy joint and ligament support
• Promotes healthy skin integrity and function
• Supports low back strength and health
• Excellent pain relief support
• Supports healthy digestion
• Extraordinary support for degranulation of the lymphatic system

Thousands of Years of Use

Devil's claw (Harpagophytum procumbens), a native to southern Africa, is named for the miniature hooks that cover its fruit.  For thousands of years, the Khoisan peoples of the Kalahari Desert have used devil's claw root in herbal remedies to help relieve pain and for pregnancy as well as for skin concerns.  Since its introduction to Europe from Africa in the early 1900s, the dried roots have been used to boost appetite, promote stomach health and to reduce pain - especially in bone and joint concerns.


What is "nanized" devil's claw?

The word "nano" means very, very small.  A "nanized" tincture of devil's claw contains premier quality devil's claw that has been "nanized" or pre-digested into very small particles which makes them extremely bio-available.  Even those with poor digestion absorb the "nanized" devil's claw.  Devil's Claw Nano-Detox really demonstrates the power of the old saying, it is not what you take, but what you absorb that makes the difference.


An Approved Pain Killer

Devil's claw is approved as a non-prescription medicine by the German Commission E, an expert panel of physicians and pharmacists who advise Germany's counterpart of the U.S. Food and Drug Administration.  Approved uses of devil's claw include loss of appetite, digestive disorders, and degenerative disorders of the locomotor system (i.e., to treat pain and inflammation in the joints).  A recent clinical study (2000) showed that this traditional African medicinal herb, devil's claw, may reduce pain associated with osteoarthritis as effectively as some conventional drugs.  In a randomized, double-blind, parallel group study conducted in France, the patients who suffered from osteoarthritis of the knee and hip received either devil's claw capsules or a pharmaceutical drug (diacerhein) for pain.  Pain relief parameters of all patients indicated that those who took devil's claw or the drug experienced similar benefits for pain relief.  However, the study also showed that patients taking devil's claw experienced significantly fewer adverse side effects than those taking the drug.  The clinical study was published in Phytomedicine, a leading European journal dealing with scientific research on herbs and phytomedicinal products.  According to Mark Blumenthal, director of the American Botanical Council, "at least two previous clinical trials on devil's claw have supported its use as an aid in treating lower back pain and rheumatic conditions.  This study is significant in that it is the first to show the potential benefits of devil's claw for osteoarthritis."  He added, "although more research is warranted, this may be good news to people who suffer from osteoarthritis, as well as their physicians, whose therapeutic choices have been fairly limited."


Research Summary

• In a randomized, double-blind study, devil's claw was shown to be as effective in eliminating pain from osteoporosis as a conventional medical drug for pain (with no adverse side effects).
• Devil's claw helped relieve arthritis-related symptoms in 630 people with degenerative joint disease. These people took devil's claw daily (3 to 9 g) for 6 months. Depending on the location of the arthritis, from 42% to 85% of the people showed improvements in their symptoms. No side effects other than mild stomach upset were reported.
• Researchers gave people with joint pain either devil's claw (2.3 g) or an inactive placebo daily for 3 to 9 weeks. People taking the devil's claw reported a significant decrease in pain and positive results compared to those taking the placebo.
• Researchers gave devil's claw or a placebo to 89 people with joint pain and inflammation. After 2 months, those who took devil's claw each day (2 g) reported less pain and greater mobility than those who took the placebo.